Stefan Boerno

Title: The Innovations of Stefan Boerno in Prostate Cancer Research

Introduction

Stefan Boerno is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cancer research, particularly in the identification of biomarkers for prostate cancer. His work focuses on the genomic regions that can aid in the diagnosis and monitoring of this disease.

Latest Patents

Stefan Boerno holds a patent related to prostate cancer markers. The invention pertains to the identification and selection of novel genomic regions that are hypermethylated in subjects with prostate cancer compared to those without. This patent encompasses nucleic acids that selectively hybridize to these genomic regions, as well as compositions and kits containing these nucleic acids. Additionally, the invention includes the use of these nucleic acids to monitor disease regression and the efficacy of therapeutic regimens in patients.

Career Highlights

Stefan Boerno is affiliated with the Max Planck Society for the Advancement of Science, where he conducts his research. His work has been instrumental in advancing the understanding of prostate cancer and developing potential diagnostic tools.

Collaborations

Stefan has collaborated with notable colleagues such as Michal Schweiger and Hans Lehrach. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Stefan Boerno's innovative work in identifying prostate cancer markers represents a significant advancement in cancer diagnostics. His contributions are vital for improving patient outcomes and enhancing therapeutic strategies.